Dextromethorphan and guaifenesin use must be monitored carefully in patients with "bad metabolizer" CYP2D6 enzyme concentrations and patients that are sedated. This mixture medication includes a huge median toxic dose (TD50) to median successful dose (ED50) ratio (or therapeutic index) in these patients. A2: If your signs persist or worsen https://laneujtcm.mybjjblog.com/a-review-of-dextromethorphan-dxm-for-sale-in-europe-43447478